Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors.
about
Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Phase I dose-escalation study ...... noma or other advanced tumors.
@en
type
label
Phase I dose-escalation study ...... noma or other advanced tumors.
@en
prefLabel
Phase I dose-escalation study ...... noma or other advanced tumors.
@en
P2093
P2860
P1433
P1476
Phase I dose-escalation study ...... noma or other advanced tumors.
@en
P2093
Antoine Hollebecque
David Pérol
Ellen Blanc
Etienne Chatelut
Helen Boyle
Philippe Cassier
Rastislav Bahleda
Sylvie Négrier
Séverine Metzger
P2860
P2888
P356
10.1186/S12885-017-3527-7
P407
P577
2017-08-15T00:00:00Z
P6179
1091206574